Louise E Vaz1, Cindi L Farnstrom1, Kimberly K Felder2, Judith Guzman-Cottrill1, Hannah Rosenberg3, Richard C Antonelli3,4. 1. Division of Pediatric Infectious Diseases, Doernbecher Children's Hospital. 2. Division of Infectious Diseases, Oregon Health & Science University, Portland. 3. Division of General Pediatrics, Department of Medicine, Boston Children's Hospital, Massachusetts. 4. Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
Abstract
BACKGROUND: Outpatient parenteral or prolonged oral antibiotic therapy (OPAT) programs reduce inpatient healthcare costs by shifting care to outpatient settings. Care coordination (CC) is a necessary component to successfully transition patients. Our objective was to assess outcomes of provider time spent on nonreimbursable CC activities in a pediatric OPAT program. METHODS: We used a qualitative feasibility pilot design and modified the Care Coordination Measurement Tool. We captured nonreimbursable CC activity and associated outcome(s) among pediatric patients enrolled in OPAT from March 1 to April 30, 2015 (44 work days) at Doernbecher Children's Hospital. We generated summary statistics for this institutional review board-waived QI project. RESULTS: There were 154 nonreimbursable CC encounters conducted by 2 infectious diseases (ID) providers for 29 patients, ages 17 months-15 years, with complex infections. Total estimated time spent on CC was 54 hours, equivalent to at least 6 workdays. Five patients with complex social issues used 37% of total CC time. Of 129 phone events, 38% involved direct contact with families, pharmacies (13%), primary care providers (13%), and home health nursing (11%). Care coordination prevented 10 emergency room (ER) visits and 2 readmissions. Care coordination led to 16 additional, not previously scheduled subspecialist and 13 primary care visits. The OPAT providers billed for 32 clinic visits during the study period. CONCLUSIONS: Nonreimbursable CC work by OPAT providers prevented readmissions and ER visits and helped facilitate appropriate healthcare use. The value of pediatric OPAT involvement in patient care would have been underestimated based on reimbursable ID consultations and clinic visits alone.
BACKGROUND: Outpatient parenteral or prolonged oral antibiotic therapy (OPAT) programs reduce inpatient healthcare costs by shifting care to outpatient settings. Care coordination (CC) is a necessary component to successfully transition patients. Our objective was to assess outcomes of provider time spent on nonreimbursable CC activities in a pediatric OPAT program. METHODS: We used a qualitative feasibility pilot design and modified the Care Coordination Measurement Tool. We captured nonreimbursable CC activity and associated outcome(s) among pediatric patients enrolled in OPAT from March 1 to April 30, 2015 (44 work days) at Doernbecher Children's Hospital. We generated summary statistics for this institutional review board-waived QI project. RESULTS: There were 154 nonreimbursable CC encounters conducted by 2 infectious diseases (ID) providers for 29 patients, ages 17 months-15 years, with complex infections. Total estimated time spent on CC was 54 hours, equivalent to at least 6 workdays. Five patients with complex social issues used 37% of total CC time. Of 129 phone events, 38% involved direct contact with families, pharmacies (13%), primary care providers (13%), and home health nursing (11%). Care coordination prevented 10 emergency room (ER) visits and 2 readmissions. Care coordination led to 16 additional, not previously scheduled subspecialist and 13 primary care visits. The OPAT providers billed for 32 clinic visits during the study period. CONCLUSIONS: Nonreimbursable CC work by OPAT providers prevented readmissions and ER visits and helped facilitate appropriate healthcare use. The value of pediatric OPAT involvement in patient care would have been underestimated based on reimbursable ID consultations and clinic visits alone.
Authors: Sara C Keller; Danielle Ciuffetelli; Warren Bilker; Anne Norris; Daniel Timko; Alex Rosen; Jennifer S Myers; Janet Hines; Joshua Metlay Journal: J Pharm Technol Date: 2013-10
Authors: Ann L N Chapman; Simon Dixon; Dawn Andrews; Patrick J Lillie; Rohit Bazaz; Julie D Patchett Journal: J Antimicrob Chemother Date: 2009-09-19 Impact factor: 5.790
Authors: Mari M Nakamura; Sara L Toomey; Alan M Zaslavsky; Jay G Berry; Scott A Lorch; Ashish K Jha; Maria C Bryant; Alexandra T Geanacopoulos; Samuel S Loren; Debanjan Pain; Mark A Schuster Journal: Acad Pediatr Date: 2014 Sep-Oct Impact factor: 3.107
Authors: Michael A Lane; Jonas Marschall; Susan E Beekmann; Philip M Polgreen; Ritu Banerjee; Adam L Hersh; Hilary M Babcock Journal: Infect Control Hosp Epidemiol Date: 2014-05-09 Impact factor: 3.254
Authors: Nathan M Krah; Tyler Bardsley; Richard Nelson; Lawanda Esquibel; Mark Crosby; Carrie L Byington; Andrew T Pavia; Adam L Hersh Journal: Hosp Pediatr Date: 2019-04
Authors: Amber B Amspoker; Houston F Lester; Christiane Spitzmueller; Candice L Thomas; Sylvia J Hysong Journal: BMC Health Serv Res Date: 2022-10-10 Impact factor: 2.908
Authors: Bernie Carter; Debra Fisher-Smith; David Porter; Steven Lane; Matthew Peak; David Taylor-Robinson; Louise Bracken; Enitan D Carrol Journal: PLoS One Date: 2021-04-02 Impact factor: 3.240